ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,516 | -3.0% | 10,200 | 0.0% | 0.04% | +2.9% |
| Q2 2023 | $37,638 | +11.5% | 10,200 | 0.0% | 0.04% | +12.9% |
| Q1 2023 | $33,762 | -14.7% | 10,200 | 0.0% | 0.03% | -20.5% |
| Q4 2022 | $39,576 | +58.3% | 10,200 | 0.0% | 0.04% | +39.3% |
| Q3 2022 | $25,000 | +19.0% | 10,200 | -1.9% | 0.03% | +27.3% |
| Q2 2022 | $21,000 | +10.5% | 10,400 | 0.0% | 0.02% | +37.5% |
| Q1 2022 | $19,000 | +26.7% | 10,400 | 0.0% | 0.02% | +23.1% |
| Q4 2021 | $15,000 | +25.0% | 10,400 | -1.0% | 0.01% | +18.2% |
| Q3 2021 | $12,000 | -29.4% | 10,500 | 0.0% | 0.01% | -26.7% |
| Q2 2021 | $17,000 | -5.6% | 10,500 | 0.0% | 0.02% | -11.8% |
| Q1 2021 | $18,000 | – | 10,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
| Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
| Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
| Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
| AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
| Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
| EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
| Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
| Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |